Moreover, it has been found that the prognostic value of AR expression seems to be dependent on the ER expression levels, and not only on the ER positivity and BC subtype determined, either by IHC or by molecular subtyping [28,29,30]. The gene discussed is ESR1; the disease is breast cancer.